IP Library › Granted Patent US 9,303,261
Granted Patent B2
US 9,303,261 · App. 14/126,505 · Granted Apr 5, 2016

Composition for controlling chromogenesis including microRNA

Inventors: Kyu Han Kim (Yongin-si, KR); Hyun Jung Choi (Yongin-si, KR); Bum Ho Bin (Yongin-si, KR); Tae Ryong Lee (Yongin-si, KR)
Assignee: Amorepacific Corporation
C12N15/1137A61K8/606A61K31/7105A61Q5/10C12N15/113G01N33/5023A61K2800/78A61K2800/782C12N2310/113C12N2310/141
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,303,261
App. No.
14/126,505
Granted
Apr 5, 2016
Kind
B2
Abstract

Disclosed is a composition for a whitening effect or for the prevention of gray hair, which includes antisense nucleic acid molecules of SEQ ID NO: 2, wherein the composition has an miRNA of SEQ ID NO: 1 or a base sequence complementary thereto. Also disclosed is a method for controlling chromogenesis in test materials and for screening for expression control materials of chromogenic genes. The composition and the screening methodcan be used for the whitening effect or for the prevention of gray hair.

Claims (15)

1. A method for screening a substance that regulates an expression of tyrosinase gene, the method comprising the steps of:

(a) transfecting a cell with a miRNA of SEQ ID NO: 1 or an antisense nucleic acid molecule of SEQ ID NO: 2;

(b) treating the cell with a test substance;

(c) determining whether the test substance inhibits the tyrosinase gene expression or whether it stimulates the tyrosinase gene expression; and

(d) determining whether color of the cell changes.

2. The method of claim 1 , further comprising, after step (c), a step of determining the test substance to be an agent that stimulates the tyrosinase gene expression, when the test substance is determined to increase the expression, activity or function of the tyrosinase gene.

3. The method of claim 1 , further comprising, after step (c), a step of determining the test substance to be an agent that inhibits the tyrosinase gene expression, when the test substance is determined to reduce the expression, activity or function of the tyrosinase gene.

4. The method of claim 1 , further comprising, after step (d), a step of determining the test substance to be an agent that stimulates the tyrosinase gene expression, when the pigmentation of the cell is determined to increase.

5. The method of claim 1 , further comprising, after step (d), a step of determining the test substance to be an agent that inhibits the tyrosinase gene expression, when the pigmentation of the cell is determined to decrease.

6. A method for whitening skin of a subject, comprising administering a composition comprising a miRNA of SEQ ID NO: 1 as an active ingredient.

7. The method of claim 6 , wherein the composition is applied externally to skin of the subject.

8. The method of claim 6 , wherein the composition is administered into the subject.

9. A method for preventing gray hair of a subject, comprising administering a composition comprising, as an active ingredient, an antisense nucleic acid molecule of SEQ ID NO: 2, which has a nucleotide sequence complementary to a miRNA of SEQ ID NO: 1 and is capable of hybridizing to the miRNA.

10. The method of claim 9 , wherein the composition is applied externally to skin of the subject.

11. The method of claim 9 , wherein the composition is administered into the subject.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2013
From: KIM, KYU HAN; CHOI, HYUN JUNG; BIN, BUM HO; LEE, TAE RYONG
To: AMOREPACIFIC CORPORATION
Reel/Frame 031818/0859 →
Priority Claims (1)
KR 10-2011-0061107 · Jun 23, 2011 · national
Continuity (1)
Related Publication 20140134636A1 · May 15, 2014